VYNE Therapeutics CEO David Domzalski's 2021 pay jumps 69% to $4.9M
VYNE Therapeutics reports 2021 executive compensation
By ExecPay News
Published: June 17, 2022
VYNE Therapeutics reported fiscal year 2021 executive compensation information on June 17, 2022.
In 2021, three executives at VYNE Therapeutics received on average a compensation package of $2.5M, a 43% increase compared to previous year.
Average pay of disclosed executives at VYNE Therapeutics
David Domzalski, Chief Executive Officer, received $4.9M in total, which increased by 69% compared to 2020. 44% of Domzalski's compensation, or $2.1M, was in option awards. Domzalski also received $243K in bonus, $638K in salary, $1.8M in stock awards, as well as $12K in other compensation.
Mutya Harsch, Chief Legal Officer, received a compensation package of $1.3M, which increased by 45% compared to previous year. 31% of the compensation package, or $407K, was in option awards.
Iain Stuart, Chief Scientific Officer, earned $1.3M in 2021.
Related executives
You may also like
Source: SEC filing on June 17, 2022.